These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32771969)

  • 1. Prostate cancer screening using chemometric processing of GC-MS profiles obtained in the headspace above urine samples.
    Deev V; Solovieva S; Andreev E; Protoshchak V; Karpushchenko E; Sleptsov A; Kartsova L; Bessonova E; Legin A; Kirsanov D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122298. PubMed ID: 32771969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
    Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
    Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
    Silva CL; Passos M; Câmara JS
    Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
    Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
    Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer.
    Guest C; Harris R; Sfanos KS; Shrestha E; Partin AW; Trock B; Mangold L; Bader R; Kozak A; Mclean S; Simons J; Soule H; Johnson T; Lee WY; Gao Q; Aziz S; Stathatou PM; Thaler S; Foster S; Mershin A
    PLoS One; 2021; 16(2):e0245530. PubMed ID: 33596212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
    Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
    Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
    Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
    Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
    Zhang S; Raftery D
    Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimisation and validation of a HS-SPME-GC-IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits.
    Calejo I; Moreira N; Araújo AM; Carvalho M; Bastos Mde L; de Pinho PG
    Talanta; 2016 Feb; 148():486-93. PubMed ID: 26653476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of volatile organic compounds with a wide range of polarities in urine by headspace solid-phase microextraction coupled to gas chromatography/mass spectrometry.
    Song HN; Kim CH; Lee WY; Cho SH
    Rapid Commun Mass Spectrom; 2017 Apr; 31(7):613-622. PubMed ID: 28085216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).
    Opitz P; Herbarth O
    J Otolaryngol Head Neck Surg; 2018 Jul; 47(1):42. PubMed ID: 29970175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a HS-SPME-GC/MS protocol assisted by chemometric tools to study herbivore-induced volatiles in Myrcia splendens.
    Souza Silva ÉA; Saboia G; Jorge NC; Hoffmann C; Dos Santos Isaias RM; Soares GLG; Zini CA
    Talanta; 2017 Dec; 175():9-20. PubMed ID: 28842040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of volatile decay markers of minced pork by headspace-solid phase microextraction-gas chromatography-mass spectrometry and chemometrics.
    Song X; Canellas E; Nerin C
    Food Chem; 2021 Apr; 342():128341. PubMed ID: 33077278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of volatile compounds as markers in geographical discrimination of Spanish extra virgin olive oils by chemometric analysis of non-specific chromatography volatile profiles.
    Pizarro C; Rodríguez-Tecedor S; Pérez-del-Notario N; González-Sáiz JM
    J Chromatogr A; 2011 Jan; 1218(3):518-23. PubMed ID: 21163487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A
    Thompson M; Sarabia Feria N; Yoshioka A; Tu E; Civitci F; Estes S; Wagner JT
    Biol Open; 2021 Mar; 10(3):. PubMed ID: 33685856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
    Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
    Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the potential of NTME/GC-MS, in the establishment of urinary volatomic profiles. Lung cancer patients as case study.
    Porto-Figueira P; Pereira J; Miekisch W; Câmara JS
    Sci Rep; 2018 Aug; 8(1):13113. PubMed ID: 30166567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simultaneous determination of various volatile organic compounds in urine by headspace GC-MS].
    Lin YR; Li TD; Liu F; Yun JP; Xie YX; Chen JH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Apr; 36(4):305-307. PubMed ID: 29996258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.